The productivity rate of drug development continues to fall, with clinical trial efficiency a driving factor. Learn more about how adaptive clinical trials can improve both predictability and efficiency.
Understand how research informed where the product may fit into the future landscape as well as how the proposed indications may restrict its use in certain markets and how it would affect the launch and market access.
AACR-NCI-EORTC 2015 -- Tumor cell viability and proliferation is regulated by the balance between tumor self-survival and host elimination mechanisms. There are multiple mechanisms whereby tumors successfully evade host immune cell surveillance, permitting continued growth and proliferation.
Breast cancers are considered poorly immunogenic tumors. However, several approaches utilizing immunotherapies are being undertaken in the clinic to evaluate their potential for improving outcomes. Radiation therapy (RT) is a highly utilized clinical treatment modality in breast cancer.